We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zealand Pharma Receives Milestone Payment from Helsinn Healthcare

News   Dec 09, 2010

 
Zealand Pharma Receives Milestone Payment from Helsinn Healthcare
 
 
 

RELATED ARTICLES

Improving Nature’s Own Ability To Kill Dangerous Bacteria

News

The ramifications of bacteria's ability to become resistant to antibiotics can be seen in hospitals, public places, our food supply, and our water. Now, researchers have demonstrated how we could improve upon the ability of nature's exquisitely selective collection of antimicrobial enzymes to attack bacteria in a way that's much less likely to cause bacterial resistance.

READ MORE

“Express Courier Service” for DNA Delivery Expected to Boost Cancer Immunotherapy

News

Immunotherapy is a promising cancer treatment that uses genetically modified immune cells to fight cancer. However, the process known as transfection to generate genetically engineered immune cells in the laboratory has poor efficiency and may have serious side effects. Now, a research team has successfully invented a novel transfection method to deliver DNA into immune cells with minimal stress on these cells.

READ MORE

A Therapeutic Counterblow to Traumatic Brain Injury

News

The secondary effects of traumatic brain injury (TBI), which can lead to long-term cognitive, psychological and motor system damage, that piqued the interest of a team of NJIT biomedical engineers. To counter them, they are developing a therapy, to be injected at the site of the injury, which shows early indications it can protect neurons and stimulate the regrowth of blood vessels in the damaged tissue.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE